Expanding HMOs potential: BASF and Glycosyn sign strategic partnership for improved gut health

The partnership facilitates the commercialization of human milk oligosaccharides (HMOs) for broad use in dietary supplements, functional nutrition and medical food

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

01 Jul 2019 --- Fourteen varieties of oligosaccharides – a type of prebiotic that aids the growth of beneficial bacteria and protects against harmful varieties in the gut... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

10 May 2019 --- French multinational Danone has granted open access to its collection of 1,800 strains of bacteria for research purposes, in celebration of the 100-year anniversary... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

01 May 2019 --- Daily consumption of chicory root fiber can keep the level of bifidobacteria higher and more stable in children aged three to six years old during antibiotic... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

27 Feb 2019 --- Swiss multinational Lonza Specialty Ingredients (LSI) and DuPont Nutrition & Health have announced a joint agreement on Human Milk Oligosaccharides (HMOs),... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

06 Nov 2018 --- BASF has launched a sports nutrition ingredient containing a unique set of plant-based peptides identified using artificial intelligence (AI), for regulating... Read More

trans